Adam Keeney
Corporate Officer/Principal en BIOGEN INC. .
Fortuna: 134 029 $ al 30/04/2024
Perfil
Adam Keeney is currently the Executive VP & Head-Corporate Development at Biogen, Inc. Prior to this, he worked as the President, Chief Executive Officer & Director at NodThera Ltd.
He completed his undergraduate degree at the University of Leeds and his doctorate at The University of Nottingham.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOGEN INC.
0.00% | 01/05/2024 | 662 ( 0.00% ) | 134 029 $ | 30/04/2024 |
Cargos activos de Adam Keeney
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 17/04/2023 |
Antiguos cargos conocidos de Adam Keeney.
| Empresas | Cargo | Fin |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Director Ejecutivo | - |
Formación de Adam Keeney.
| The University of Nottingham | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Adam Keeney
